PHASE II STUDY OF COMBINATION CHEMOTHERAPY WITH ORAL S-1 AND OXALIPLATIN (SOX) IN PATIENTS WITH MUCINOUS ADENOCARCINOMA OF THE OVARY

被引：0
|
作者：
Nishio, S. [1 ]
Shimada, M. [2 ]
Kamura, T. [1 ]
Ishitani, K. [3 ]
Ochiai, K. [4 ]
Takeshima, N. [5 ]
Yokoyama, Y. [6 ]
Furumoto, H. [7 ]
Sugiyama, T. [8 ]
Kigawa, J. [2 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan
[2] Tottori Univ, Yonago, Tottori, Japan
[3] Tokyo Womens Med Univ, Tokyo, Japan
[4] Jikei Univ, Sch Med, Tokyo, Japan
[5] Canc Inst Hosp, Tokyo, Japan
[6] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan
[7] Univ Tokushima, Grad Sch, Tokushima, Japan
[8] Iwate Med Univ, Sch Med, Morioka, Iwate 020, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [31] A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
    Inkeun Park
    Min-Hee Ryu
    Yoon Hee Choi
    Hyo Jeong Kang
    Jeong Hwan Yook
    Young Soo Park
    Hyun Jin Kim
    Hwoon-Yong Jung
    Gin Hyug Lee
    Kab Choong Kim
    Byung Sik Kim
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 815 - 823
  • [32] RANDOMIZED PHASE II TRIAL OF S-1 VERSUS S-1 PLUS OXALIPLATIN (SOX) IN PATIENTS WITH GEMCITABINE REFRACTORY PANCREATIC CANCER
    Okusaka, T.
    Ohkawa, S.
    Isayama, H.
    Fukutomi, A.
    Yamaguchi, K.
    Ikeda, M.
    Funakoshi, A.
    Nagase, M.
    Nakamori, S.
    Hamamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 241 - 242
  • [33] Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
    Wang, Fei-Yu
    Huang, Xiang-Ming
    Cao, Yu-Qing
    Cao, Jie
    Song, Meng
    Fang, Zhi-Jun
    Huang, Xin-En
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
  • [34] Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
    Zang, D. Y.
    Lee, B. H.
    Park, H. -C.
    Song, H. H.
    Kim, H. J.
    Jung, J. Y.
    Kim, J. H.
    Kim, H. Y.
    Kwon, J. H.
    Hwang, S. W.
    Park, S. R.
    Park, C. H.
    Kim, K. O.
    Kim, M. -J.
    Jang, K. M.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 892 - 896
  • [35] Combination Chemotherapy with S-1 and Oxaliplatin (SOX) as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer
    Zhong, Dong-ta
    Wu, Ri-ping
    Wang, Xin-li
    Huang, Xiao-bing
    Lin, Meng-xin
    Lan, Yan-qin
    Chen, Qiang
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 867 - 873
  • [36] A phase II study for triplet combination of oxaliplatin, irinotecan, and S-1 in patients with metastatic or recurrent gastric cancer
    Han, B.
    Park, S. R.
    Kim, H. S.
    Ryu, M-H.
    Kim, J-S.
    Rho, S-Y.
    Kang, B. W.
    Lee, K. H.
    Rha, S. Y.
    Kang, W. K.
    Kang, Y-K.
    Zang, D. Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] Fruquintinib plus oxaliplatin combined with S-1 (SOX) as neoadjuvant therapy for locally advanced gastric adenocarcinoma (FRUTINEOGA): A multicenter, phase II study
    Wu, Liucheng
    Qin, Yuzhou
    Huang, Mingwei
    Long, Di
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Phase I study of oral S-1 in combination with oxaliplatin (oxali) and bevacizumab (bev) in patients with advanced solid tumors
    Zhang, J.
    Chung, K.
    Zergebel, C.
    Urrea, P.
    Quinones, M.
    Saltz, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Multicenter phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PII)
    Kondo, Masato
    Satake, Hironaga
    Mizumoto, Motoko
    Miki, Akira
    Watanabe, Takanori
    Tanaka, Norimitsu
    Hirata, Kenro
    Tanioka, Hiroaki
    Okita, Yoshihiro
    Kyogoku, Takahisa
    Tatsumi, Mitsutoshi
    Matoba, Koreatsu
    Adachi, Shinichi
    Kaihara, Satoshi
    Yasui, Hisateru
    Tsuji, Akihito
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [40] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Do-Youn Oh
    Yongjun Cha
    In-Sil Choi
    So-Young Yoon
    In Keun Choi
    Jee Hyun Kim
    Sang Cheul Oh
    Chang Duck Kim
    Jae Sun Kim
    Yung-Jue Bang
    Yeul Hong Kim
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 527 - 536
12345